Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis

Free Radic Biol Med. 2003 Jul 1;35(1):45-58. doi: 10.1016/s0891-5849(03)00244-2.

Abstract

Current evidence suggests that amyloid beta peptides (Abeta) may play a major role in the pathogenesis of Alzheimer's disease by eliciting oxidative stress and neuronal apoptosis. In this study we have used differentiated SK-N-BE neurons to investigate molecular mechanisms and regulatory pathways underlying apoptotic neuronal cell death elicited by Abeta(1-40) and Abeta(1-42) peptides as well as the relationships between apoptosis and oxidative stress. Abeta peptides, used at concentrations able to induce oxidative stress, elicit a classic type of neuronal apoptosis involving mitochondrial regulatory proteins and pathways (i.e. affecting Bax and Bcl-2 protein levels as well as release of cytochrome c in the cytosol), poly-ADP rybose polymerase cleavage and activation of caspase 3. This pattern of neuronal apoptosis, that is significantly prevented by alpha-tocopherol and N-acetylcysteine and completely abolished by specific inhibitors of stress-activated protein kinases (SAPK) such as JNKs and p38(MAPK), involved early elevation of p53 protein levels. Pretreatment of neurons with alpha-pifithrin, a specific p53 inhibitor, resulted in a 50-60% prevention of Abeta induced apoptosis. These results suggest that oxidative stress - mediated neuronal apoptosis induced by amyloid beta operates by eliciting a SAPK-dependent multiple regulation of pro-apoptotic mitochondrial pathways involving both p53 and bcl-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Amyloid beta-Peptides / pharmacology*
  • Apoptosis / drug effects*
  • Benzothiazoles
  • Caspase 3
  • Caspases / metabolism
  • Cell Differentiation
  • Cytochromes c / metabolism
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Hydrogen Peroxide / metabolism
  • JNK Mitogen-Activated Protein Kinases*
  • MAP Kinase Kinase 4
  • Mitochondria / metabolism
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology*
  • Oxidative Stress / drug effects*
  • Peptide Fragments / pharmacology*
  • Poly(ADP-ribose) Polymerases / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Thiazoles / pharmacology
  • Toluene / analogs & derivatives*
  • Toluene / pharmacology
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / metabolism
  • alpha-Tocopherol / pharmacology
  • bcl-2-Associated X Protein
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Amyloid beta-Peptides
  • BAX protein, human
  • Benzothiazoles
  • Enzyme Inhibitors
  • Peptide Fragments
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Thiazoles
  • Tumor Suppressor Protein p53
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • bcl-2-Associated X Protein
  • Toluene
  • Cytochromes c
  • Hydrogen Peroxide
  • pifithrin
  • Poly(ADP-ribose) Polymerases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • alpha-Tocopherol
  • Acetylcysteine